Global Peripheral Vascular Thrombectomy Devices Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Peripheral Vascular Thrombectomy Devices Market Size

• The global peripheral vascular thrombectomy devices market size was valued at USD 684.99 million in 2025 and is expected to reach USD 1,134.50 million by 2033, at a CAGR of 6.51% during the forecast period
• The market growth is largely fueled by the increasing prevalence of peripheral vascular diseases, rising geriatric population, and the growing adoption of minimally invasive vascular interventions
• Furthermore, technological advancements in thrombectomy devices, coupled with increasing awareness among healthcare providers and patients about effective treatment options, are driving the demand for these devices. These converging factors are accelerating the adoption of peripheral vascular thrombectomy solutions, thereby significantly boosting the industry's growth

Peripheral Vascular Thrombectomy Devices Market Analysis

• Peripheral vascular thrombectomy devices, designed for the mechanical removal of blood clots from peripheral arteries and veins, are increasingly vital in the treatment of peripheral vascular diseases due to their minimally invasive nature, improved patient outcomes, and reduced procedure times compared to traditional surgical interventions
• The escalating demand for peripheral vascular thrombectomy devices is primarily fueled by the rising prevalence of peripheral artery disease (PAD), increasing geriatric population, and growing preference for minimally invasive endovascular procedures over open surgeries
• North America dominated the peripheral vascular thrombectomy devices market with the largest revenue share of 39.2% in 2025, characterized by advanced healthcare infrastructure, high adoption of cutting-edge medical technologies, and a strong presence of key device manufacturers, with the U.S. witnessing substantial growth in thrombectomy procedures driven by innovations in catheter-based systems and aspiration technologies
• Asia-Pacific is expected to be the fastest growing region in the peripheral vascular thrombectomy devices market during the forecast period due to increasing healthcare expenditure, rising awareness about vascular disease management, and expanding access to advanced interventional procedures
• Aspiration thrombectomy devices segment dominated the market with a share of 41.9% in 2025, driven by their proven efficacy, ease of use, and compatibility with diverse vascular anatomies

Report Scope and Peripheral Vascular Thrombectomy Devices Market Segmentation

Peripheral Vascular Thrombectomy Devices Market Trends

Increasing Adoption of Combination and Advanced Thrombectomy Technologies

• A significant and accelerating trend in the global peripheral vascular thrombectomy devices market is the growing adoption of combination devices that integrate mechanical clot removal with drug delivery or aspiration systems, improving procedural efficiency and patient outcomes
  • For instance, the Penumbra Indigo System combines aspiration thrombectomy with advanced catheter technology to safely remove peripheral clots while minimizing vessel trauma, gaining traction in hospitals and vascular centers
• Technological innovations such as AI-assisted imaging, improved catheter flexibility, and real-time thrombus visualization are enabling more precise interventions, reducing complications, and enhancing procedural success rates
• The integration of these devices with advanced imaging platforms facilitates targeted treatment, enabling clinicians to plan and execute interventions with higher accuracy and reduced procedure time
• This trend toward smarter, multifunctional, and minimally invasive thrombectomy solutions is fundamentally reshaping treatment strategies for peripheral vascular disease. Consequently, companies such as Boston Scientific and Penumbra are developing next-generation devices with features such as enhanced clot aspiration efficiency and improved catheter navigability
• The demand for advanced thrombectomy devices that offer integrated, minimally invasive, and precise clot removal solutions is growing rapidly across hospitals and interventional centers, as healthcare providers increasingly prioritize patient safety and procedural efficiency
• Expansion of telemedicine and remote monitoring technologies is supporting better post-procedure follow-up and patient management, enhancing the overall value proposition of thrombectomy interventions

Peripheral Vascular Thrombectomy Devices Market Dynamics

Driver

Rising Prevalence of Peripheral Vascular Diseases and Minimally Invasive Treatment Preference

• The increasing prevalence of peripheral artery disease (PAD), deep vein thrombosis (DVT), and other vascular conditions, coupled with the growing preference for minimally invasive endovascular interventions, is a significant driver for the heightened demand for thrombectomy devices
  • For instance, in March 2025, Penumbra, Inc. reported expanded clinical adoption of its Indigo System for treating peripheral arterial thrombus, highlighting improved procedural outcomes and faster patient recovery times
• As patients and healthcare providers seek safer alternatives to open surgery, thrombectomy devices offer advanced solutions such as targeted clot removal, reduced risk of complications, and shorter hospital stays, providing a compelling advantage over traditional methods
• Furthermore, rising awareness about early diagnosis and treatment of vascular disorders is making thrombectomy procedures an essential component of modern vascular care, enabling better management of acute and chronic conditions
• The combination of increasing incidence of vascular diseases, demand for minimally invasive treatments, and healthcare infrastructure improvements are key factors propelling the adoption of peripheral vascular thrombectomy devices in hospitals, clinics, and specialized vascular centers
• Growing investment in research and development by leading device manufacturers to enhance device efficacy, safety, and ease of use is further driving market growth
• Increasing government and private initiatives to improve vascular care awareness and accessibility in emerging markets are creating new growth opportunities for thrombectomy devices

Restraint/Challenge

High Device Costs and Regulatory Approval Complexities

• The relatively high cost of advanced thrombectomy devices compared to traditional surgical methods poses a significant challenge to broader market penetration, particularly in price-sensitive regions and smaller healthcare facilities
  • For instance, reports from smaller clinics in emerging markets indicate that the adoption of premium devices such as the AngioJet Thrombectomy System is limited due to budget constraints and high procedural costs
• Navigating stringent regulatory approval processes across different regions also presents hurdles, as manufacturers must comply with extensive clinical trial requirements, quality certifications, and device safety standards before market entry
• While ongoing innovation is reducing procedural complexity and improving efficiency, the initial investment in devices, training, and associated infrastructure can deter adoption among healthcare providers with limited resources
• Overcoming these challenges through cost-optimization strategies, simplified device designs, faster regulatory approvals, and healthcare provider education will be vital for sustained market growth and wider accessibility of thrombectomy solutions
• Limited awareness among patients and some healthcare providers about the benefits of advanced thrombectomy procedures can slow adoption in certain regions
• Potential complications or procedural risks associated with thrombectomy, such as vessel injury or incomplete clot removal, may make clinicians cautious, impacting the uptake of these devices

Peripheral Vascular Thrombectomy Devices Market Scope

The market is segmented on the basis of product type, device type, and end use.

• By Product Type

On the basis of product type, the market is segmented into aspiration thrombectomy devices, ultrasonic thrombectomy devices, mechanical thrombectomy devices, and others. The aspiration thrombectomy devices segment dominated the market with the largest revenue share of 41.9% in 2025, driven by their proven efficacy in removing clots with minimal vessel trauma and their compatibility with diverse vascular anatomies. Hospitals and interventional centers often prefer aspiration systems for their reliability and ease of use in treating both acute and chronic thrombotic conditions. The segment also benefits from continuous technological innovations such as improved catheter designs, stronger aspiration pumps, and integration with imaging systems, which enhance procedural precision and success rates. The availability of a wide range of device sizes and configurations further contributes to the segment’s dominance across various patient populations.

The ultrasonic thrombectomy devices segment is anticipated to witness the fastest growth rate from 2026 to 2033 due to increasing adoption in complex peripheral arterial cases where combined mechanical and ultrasound energy provides enhanced clot removal efficiency. Ultrasonic devices minimize procedural risks and shorten recovery times, making them appealing in high-volume vascular centers. Rising awareness among clinicians about the benefits of less invasive and more effective thrombectomy techniques is boosting the adoption of ultrasonic systems. Moreover, ongoing advancements in device miniaturization and flexibility are expanding their applicability to smaller vessels and challenging anatomies.

• By Device Type

On the basis of device type, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other devices. The catheters segment dominated the market with the largest revenue share in 2025, driven by their essential role in delivering thrombectomy devices safely and effectively to target vascular sites. Catheters are central to procedural success, and improvements in materials, flexibility, and navigation capabilities have strengthened their market position. Their compatibility with multiple thrombectomy systems, including aspiration and mechanical devices, makes them a preferred choice in interventional procedures. The segment also benefits from rising procedural volumes of peripheral vascular interventions and the increasing prevalence of PAD and DVT.

The plaque modification devices segment is expected to witness the fastest CAGR from 2026 to 2033, fueled by growing adoption in complex peripheral lesions requiring adjunctive therapies before clot removal. These devices improve procedural outcomes by optimizing vessel lumen and facilitating easier clot extraction, particularly in calcified or occluded vessels. Advancements in device design, such as rotational atherectomy or orbital systems, are expanding their adoption in specialized vascular centers. Increasing clinician awareness of their clinical benefits and integration with thrombectomy procedures is further driving segment growth.

• By End Use

On the basis of end use, the market is segmented into hospitals, clinics, ambulatory centers, and others. The hospitals segment dominated the market in 2025, accounting for the largest revenue share, driven by their advanced infrastructure, presence of skilled interventional cardiologists and radiologists, and higher procedural volumes. Hospitals are the preferred setting for complex thrombectomy procedures due to availability of imaging facilities, post-procedure care, and multidisciplinary teams. The segment also benefits from continuous investment in high-end thrombectomy technologies and training programs for clinicians.

The ambulatory clinics segment is expected to witness the fastest growth during the forecast period due to increasing adoption of minimally invasive thrombectomy procedures that can be safely performed in outpatient settings. Growing patient preference for shorter hospital stays, combined with advancements in portable and user-friendly thrombectomy devices, is driving this trend. Expansion of outpatient vascular centers and favorable reimbursement policies for day-care interventions are also contributing to segment growth. This shift enables wider accessibility of thrombectomy procedures to patients while reducing overall healthcare costs.

Peripheral Vascular Thrombectomy Devices Market Regional Analysis

• North America dominated the peripheral vascular thrombectomy devices market with the largest revenue share of 39.2% in 2025, characterized by advanced healthcare infrastructure, high adoption of cutting-edge medical technologies, and a strong presence of key device manufacturers
• Healthcare providers in the region highly value the precision, minimally invasive nature, and improved patient outcomes offered by thrombectomy devices, making them a preferred choice for hospitals and specialized vascular centers
• This widespread adoption is further supported by increasing government and private healthcare spending, a strong presence of key device manufacturers, and growing awareness among clinicians regarding the benefits of catheter-based clot removal procedures

U.S. Peripheral Vascular Thrombectomy Devices Market Insight

The U.S. peripheral vascular thrombectomy devices market captured the largest revenue share of 42% in 2025 within North America, fueled by the increasing prevalence of peripheral artery disease (PAD) and deep vein thrombosis (DVT). Healthcare providers are prioritizing minimally invasive interventions to reduce complications and improve patient recovery times. The growing adoption of advanced thrombectomy systems, supported by cutting-edge imaging technologies and catheter-based solutions, further propels the market. Moreover, the presence of key device manufacturers and continuous clinical innovations are significantly contributing to the market’s expansion, making the U.S. a dominant hub for peripheral vascular interventions.

Europe Peripheral Vascular Thrombectomy Devices Market Insight

The Europe peripheral vascular thrombectomy devices market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing prevalence of vascular diseases and stringent clinical guidelines for early intervention. Rising healthcare infrastructure, urbanization, and demand for minimally invasive endovascular procedures are fostering the adoption of thrombectomy devices. European healthcare providers are increasingly integrating advanced aspiration and mechanical thrombectomy systems into hospitals and specialized vascular centers. The market is also experiencing growth in peripheral interventions for both acute and chronic conditions, with a strong focus on patient safety and procedural efficiency.

U.K. Peripheral Vascular Thrombectomy Devices Market Insight

The U.K. peripheral vascular thrombectomy devices market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising awareness of peripheral vascular disorders and preference for minimally invasive procedures. Increasing demand for outpatient vascular interventions and integration of advanced thrombectomy technologies in hospitals and clinics are key growth factors. In addition, government initiatives to improve vascular disease diagnosis and treatment accessibility are supporting market expansion. The U.K. market benefits from a robust healthcare infrastructure and a focus on clinical research, which encourages adoption of innovative devices such as aspiration and ultrasonic thrombectomy systems.

Germany Peripheral Vascular Thrombectomy Devices Market Insight

The Germany peripheral vascular thrombectomy devices market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing prevalence of PAD, DVT, and other vascular conditions. Germany’s well-developed healthcare system, high adoption of minimally invasive technologies, and emphasis on clinical safety promote the use of thrombectomy devices in hospitals and specialized centers. Integration with advanced imaging platforms and growing awareness among clinicians regarding procedural benefits further drive adoption. The market also sees demand for eco-friendly and cost-efficient thrombectomy solutions that reduce procedure time and improve patient outcomes.

Asia-Pacific Peripheral Vascular Thrombectomy Devices Market Insight

The Asia-Pacific peripheral vascular thrombectomy devices market is poised to grow at the fastest CAGR of 23% during the forecast period of 2026 to 2033, driven by increasing incidence of vascular diseases, rapid urbanization, and rising healthcare expenditure in countries such as China, Japan, and India. The region’s expanding healthcare infrastructure, along with government initiatives to promote early intervention and minimally invasive procedures, is accelerating market adoption. In addition, the growing number of vascular intervention centers and availability of cost-effective thrombectomy devices are making these treatments accessible to a wider patient base.

Japan Peripheral Vascular Thrombectomy Devices Market Insight

The Japan peripheral vascular thrombectomy devices market is gaining momentum due to the country’s aging population, high prevalence of PAD, and strong focus on advanced healthcare technologies. Hospitals and specialized vascular centers are increasingly adopting minimally invasive thrombectomy procedures to improve patient outcomes. Integration with imaging guidance and precision catheter systems enhances procedural safety and efficiency. Moreover, Japan’s emphasis on preventive vascular care and the expansion of outpatient interventional centers are fueling demand for reliable thrombectomy solutions across residential and commercial healthcare facilities.

India Peripheral Vascular Thrombectomy Devices Market Insight

The India peripheral vascular thrombectomy devices market accounted for the largest market revenue share in Asia-Pacific in 2025, attributed to rising prevalence of vascular disorders, growing healthcare awareness, and improving hospital infrastructure. India is witnessing increasing adoption of minimally invasive procedures in tertiary care hospitals and vascular specialty centers. Government initiatives to expand access to advanced healthcare services, along with availability of affordable thrombectomy devices, are key factors propelling market growth. In addition, the growing number of skilled interventional cardiologists and radiologists is further supporting the adoption of peripheral vascular thrombectomy procedures across the country.

Peripheral Vascular Thrombectomy Devices Market Share

The Peripheral Vascular Thrombectomy Devices industry is primarily led by well-established companies, including:

• Boston Scientific Corporation (U.S.)
• Medtronic (Ireland)
• Cook (U.S.)
• Teleflex Incorporated (U.S.)
• AngioDynamics, Inc. (U.S.)
• Abbott (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Argon Medical Devices, Inc. (U.S.)
• Terumo Corporation (Japan)
• Stryker (U.S.)
• LeMaitre Vascular (U.S.)
• Acandis GmbH (Germany)
• Phenox GmbH (Germany)
• Straub Medical AG (Switzerland)
• Walk Vascular, LLC (U.S.)
• Inari Medical, Inc. (U.S.)
• Abbott Vascular Enterprises (U.S.)
• Merit Medical Systems, Inc. (U.S.)
• Baxter (U.S.)

What are the Recent Developments in Global Peripheral Vascular Thrombectomy Devices Market?

• In January 2026, Boston Scientific announced its agreement to acquire Penumbra, Inc., a leading thrombectomy‑device maker, in a strategic move that will significantly expand Boston Scientific’s vascular and thrombus‑removal product portfolio when the deal closes
• In December 2025, Medtronic announced the first commercial use of its Liberant Thrombectomy System, a mechanical aspiration thrombectomy platform for removing fresh emboli/thrombi in both peripheral arterial and venous systems, marking its initial real‑world application
• In April 2025, Surmodics began the full commercial release of its Pounce™ XL Thrombectomy System, for rapid endovascular removal of acute and chronic clots from larger peripheral arteries, with use in vessels such as the iliac and femoral
• In March 2025, Inari Medical (now part of Stryker) launched the Artix™ Thrombectomy System, a combined aspiration plus mechanical thrombectomy solution designed for peripheral arterial thromboembolism, aiming to provide greater procedural control and versatility in clot removal
• In April 2024, Expanse ICE’s ICE Aspiration System received 510(k) FDA clearance specifically for thrombectomy in peripheral arterial and venous vessels, expanding treatment options in this sector
• https://www.stryker.com/us/en/about/news/2025/inari-medical-stryker-launches-artix-thrombectomy-system.html
• https://evtoday.com/news/surmodics-begins-full-commercial-release-of-pounce-xl-thrombectomy-system
• https://news.bostonscientific.com/2026-01-15-Boston-Scientific-announces-agreement-to-acquire-Penumbra%2C-Inc
• https://www.dicardiology.com/content/innovative-aspiration-thrombectomy-system-expanse-ice-receives-fda-clearance-vessel
• https://www.dicardiology.com/content/medtronic-announces-first-commercial-use-thrombectomy-system

SKU-65739